Contemporary use of devices in chronic heart failure in the Netherlands

Contemporary use of devices in chronic heart failure in the Netherlands

Abstract Aims Despite previous surveys regarding device implantation rates in heart failure (HF), insight into the real‐world management with devices is scarce. Therefore, we investigated device implantation rates in HF with reduced left ventricular ejection fraction (LVEF) in 34 Dutch centres. Meth...

Full description

Bibliographic Details
Main Authors:	Anne G. Raafs, Gerard C.M. Linssen, Jasper J. Brugts, Ayten Erol‐Yilmaz, Jacobus Plomp, Jeroen P.P. Smits, Michiel J. Nagelsmit, Remko M. Oortman, Arno W. Hoes, Hans‐Peter Brunner‐LaRocca
Format:	Article
Language:	English
Published:	Wiley 2020-08-01
Series:	ESC Heart Failure
Subjects:	Heart failure Electrical device therapy Implantable cardioverter defibrillator Cardiac resynchronization therapy Real‐world heart failure management
Online Access:	https://doi.org/10.1002/ehf2.12740

Similar Items

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs
by: Dominic A. M. J. Theuns, et al.
Published: (2021-05-01)

Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure
by: Yitschak Biton, et al.
Published: (2019-03-01)

Long-term clinical outcomes after upgrade to resynchronization therapy: A propensity score–matched analysis
by: Mariana Brandão, MD, MSc, et al.
Published: (2021-12-01)

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis
by: Kilian Fischer, et al.
Published: (2022-02-01)

Current status of implantable defibrillator devices in patients with left ventricular dysfunction — The first report from the online registry database
by: Akihiko Shimizu, MD, et al.
Published: (2008-01-01)

Biventricular pacemaker and defibrillator implantation in patients with chronic heart failure in China
by: Dejia Huang, et al.
Published: (2021-02-01)

Cardiac Resynchronization Therapy: Who Benefits?
by: Jason S. Chinitz, et al.
Published: (2014-04-01)

The Role of Daily Implant-Based Multiparametric Telemonitoring in Patients with a Ventricular Assist Device
by: Denise Guckel, et al.
Published: (2022-12-01)

Interventional challenges due to venous occlusion during cardiac resynchronization therapy in patients with prior cardioverter-defibrillator implantation: Case report
by: Veysel Kutay Vurgun, et al.
Published: (2016-07-01)

Cardiac magnetic resonance defines mechanisms of sex-based differences in outcomes following cardiac resynchronization therapy
by: Derek J. Bivona, et al.
Published: (2022-09-01)

Evaluation of potential underuse of cardiac resynchronization therapy for heart failure with reduced ejection fraction
by: Makoto Takano, et al.
Published: (2021-12-01)

HeartLogic multisensor algorithm response prior to ventricular arrhythmia events
by: Shohei Kataoka, et al.
Published: (2023-10-01)

Cardiac Resynchronization Therapy Defibrillator Treatment in a Child with Heart Failure and Ventricular Arrhythmia
by: Hak Ju Kim, et al.
Published: (2016-08-01)

Trends and determinant factors in the use of cardiac resynchronization therapy devices in Japan: Analysis of the Japan cardiac device treatment registry database
by: Hisashi Yokoshiki, et al.
Published: (2016-12-01)

Clinical outcomes of cardiac resynchronization therapy with and without a defibrillator in elderly patients with heart failure
by: Simon Christie, et al.
Published: (2019-02-01)

Guideline-directed device therapies in heart failure: A clinical practice-based analysis using electronic health record data
by: Anne B. Curtis, et al.
Published: (2022-04-01)

Devices in Heart Failure Patients—Who Benefits From ICD and CRT?
by: Alexander Breitenstein, et al.
Published: (2019-08-01)

Redox imbalance in patients with heart failure and ICD/CRT-D intervention. Can it be an underappreciated and overlooked arrhythmogenic factor? A first preliminary clinical study
by: Jakub Szyller, et al.
Published: (2023-11-01)

Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement
by: Thomas Beiert, et al.
Published: (2018-04-01)

Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients
by: Rakesh Gopinathannair, et al.
Published: (2018-06-01)

Impact of diabetes on clinical outcome of patients with heart failure undergoing ICD and CRT procedures: results from the German Device Registry
by: Elif Kaya, et al.
Published: (2020-06-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

THE SIGNIFICANCE OF FUNCTIONAL AND ETIOLOGICAL DIAGNOSTIC FOR TREATMENT STRATEGY DECISION IN PATIENTS WITH DILATED CARDIOMYOPATHY
by: Yu. V. Frolova
Published: (2014-05-01)

Predicting the survival benefit of cardiac resynchronization therapy with defibrillator function for non-ischemic heart failure—Role of the Goldenberg risk score
by: Eperke D. Merkel, et al.
Published: (2023-01-01)

Remotely Monitored Cardiac Implantable Electronic Device Data Predict All‐Cause and Cardiovascular Unplanned Hospitalization
by: Camilla Sammut‐Powell, et al.
Published: (2022-08-01)

Premature ventricular contractions in patients with an implantable cardioverter defibrillator cardiac resynchronization therapy device: Results from the UMBRELLA registry
by: Finn Akerström, et al.
Published: (2020-05-01)

The Miniaturization of Cardiac Implantable Electronic Devices: Advances in Diagnostic and Therapeutic Modalities
by: Richard G. Trohman, et al.
Published: (2019-09-01)

Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation
by: Antonio Rapacciuolo, et al.
Published: (2021-12-01)

Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study
by: Johanna Mueller‐Leisse, et al.
Published: (2021-12-01)

Embodied Revelation: A Classic Grounded Theory of Heart Failure Patient Decision Making Surrounding Primary Prevention Implantable Cardioverter Defibrillator Therapy
by: Vera Barton-Caro Ph.D.,
Published: (2015-12-01)

Effect of defibrillation on the performance of an implantable vagus nerve stimulation system
by: Imad Libbus, et al.
Published: (2021-03-01)

Negative effects of COVID‐19 on the implantation rate of cardiac resynchronization therapy with defibrillator device
by: Anmol Johal, et al.
Published: (2024-04-01)

The role of AV and VV optimization for CRT
by: William W. Brabham, M.D., et al.
Published: (2013-06-01)

Compliance with Guideline-Directed Medical Therapy and Early Implantable Cardioverter-Defibrillator Activation in Heart Failure: A Retrospective Study
by: Ivan Prepolec, et al.
Published: (2024-02-01)

INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact)
by: Claudius Hansen, et al.
Published: (2018-06-01)

The contribution of implantable cardioverter defibrillators to systemic inflammation in heart failure patients
by: Ozcan Orscelik, et al.
Published: (2019-06-01)

Cardiac Resynchronization Therapy in Heart Failure Management
by: Hilman Zulkifli Amin, et al.
Published: (2016-05-01)

OPTIMIZACIÓN DE LA DE RESINCRONIZACIÓN TRAS ACORTAMIENTO DEL RETARDO AURÍCULO-VENTRICULAR / Optimization of resynchronization after shortening of atrioventricular delay
by: Damián Pérez Cabrera, et al.
Published: (2012-03-01)

RESYNCHRONIZATION THERAPY IN PATIENTS WITH HEART FAILURE
by: Tomislav Kostić, et al.
Published: (2013-06-01)

Pacemaker optimization guided by echocardiography in cardiac resynchronization therapy
by: Trifunović Danijela, et al.
Published: (2009-01-01)